__________________________________________________________________________________________
23/MAY/2014
Re: Local ID TH140400670 / TH201404002454 FU (1)
Thank you for reporting to us a serious adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – spine infection, involving a female patient, 78 yrs who was subscribed Forteo, reported the event to Lilly on 04/APR/2014.
Please try to obtain the following information:
1. What was medical history of the patient and concomitant medication?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. What was the start date of the event?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Was the patient hospitalized? If yes, When? When was patient discharged?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. What was the corrective treatment?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. Did the patient undergo any exam?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Was teriparatide reintroduced?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
7. What was type of infection (vertebral osteomyelitis, discitis, epidural abscess, other) and cause of the event?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
8. What was the relatedness opinion?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: